Hasanain Shakir Mahmood

Prof. Dr. Hasanain Shakir Mahmood

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2018 in International Journal of Applied Pharmaceutics
Verified
Journal Article
Open access
MAMaryam Alaayedi
Maryam Alaayedi
HMHasanain Shakir Mahmood
Hasanain Shakir Mahmood
ASAshti Saeed
Ashti Saeed
Objective: The object of this study was to improve flurbiprofen permeability transdermally using castor oil as penetration enhancer.Methods: Castor oil with different concentrations (1%, 2%, 3%, 4%, and 5%) was used in this study as a natural enhancer to improve flurbiprofen permeation transdermally as a gel. The formulated gel of the drug was evaluated for several physicochemical characteristics. The in vitro release and permeability studies for the drug were performed using Franz cell diffusion apparatus across the synthetic membrane. Korsmeyer Pappas kinetic model was used to study the release mechanism of flurbiprofen from the gel.Results: The results demonstrated that castor oil was safe with no skin irritation and the formulas were stable over time. Castor oil was significantly effective in increasing the percent of flurbiprofen permeability from 46%±2.9 for the gel without enhancer to 95%±2 for the gel with 5% castor oil and increasing its penetration is directly related to the oil concentration. Two mechanisms for the drug release from the gel were involved, which are non-Fickian (anomalous) and super case II transport.Conclusion: Flurbiprofen gel was prepared and evaluated successfully for an in vitro parameters with a good permeation across a synthetic membrane. The results demonstrated that castor oil had an effective enhancement for permeation of flurbiprofen.

1 January 2022 in Journal of Population Therapeutics and Clinical Pharmacology
Verified
Journal Article
Closed access
RARiyam Bassil Ali
Riyam Bassil Ali
MAMajid Hameed Ahmed
Majid Hameed Ahmed
HIHaidar K Ibrahim
Haidar K Ibrahim
HMHasanain Shakir Mahmood
Hasanain Shakir Mahmood
Hepcidin is a hormone that contributes to iron homeostasis, produced either through hepatic or extrahepatic pathways. Its production may be affected by proinflammatory mediators released by macrophages, which play a role in the development of peripheral insulin resistance. Insulin itself may increase the production of hepcidin hormone from pancreatic β-cells. To evaluate the impact of induction of type 2 diabetes mellitus (T2DM) in albino wister rats on the level of hepcidin. Also, to examine the role of 2-week use of Empagliflozin, a sodium-glucose cotransporter-2 inhibitor (SGLT2 Inhibitor), on the hepcidin level comparing to control. An interventional study includes randomization of 36 rats into three groups (A: negative control, B: positive control, and C: Empagliflozin group). Two rats were excluded from the study for different reasons. T2DM was induced using high-fat diet/high-sugar diet (HFD/HSD) for 8 weeks. Empagliflozin was then given to Group C for 2 weeks at a dose of 35 mg/kg/day. Hepcidin level was determined at the baseline, and at week 8 and week 10 intervals. Hepcidin was determined using enzyme-linked immunosorbent assay (ELISA). Hepcidin level significantly increased following the induction of T2DM in both B and C Groups. Hepcidin level in Group B insignificantly reduced 2 weeks after discontinuation of HFD/HSD and significantly reduced in Group C. Group A experienced no statistical difference in hepcidin level at week 10 when compared to baseline. Induction of T2DM is associated with a significant increase in the level of hepcidin. Empagliflozin significantly reduced hepcidin level in newly induced diabetic rats.

8 January 2026 in Gels
Verified
Journal Article
Open access
PDF file
MMMasar Basim Mohsin Mohamed
Masar Basim Mohsin Mohamed
GHGhaidaa S. Hameed
Ghaidaa S. Hameed
MSMohanad Naji Sahib
Mohanad Naji Sahib
ZKZainab Saad Kadorri
Zainab Saad Kadorri
HMHasanain Shakir Mahmood
Hasanain Shakir Mahmood
AKAqeel Abdulridha Khudhair
Aqeel Abdulridha Khudhair
(1) Background: Gastroretentive systems are an interesting option for enhancing the bioavailability of weak bases and poorly soluble drugs. The aim of this study was to formulate supramolecular organogels based on cinnarizine (CIN) as a potential gastroretentive system. (2) Methods: The organogels were prepared with different oils in different ratios. Thereafter, their pharmaceutical characteristics and in vitro gastric retention were evaluated through in vitro and in silico simulations. (3) Results: Organogels with different proportions of CIN to oils were successfully obtained. The DSC thermal analysis results demonstrated that all organogels showed gel–sol temperature transitions. The frequency sweep test verified that all organogels presented frequency-independent behavior. Optical imaging revealed longitudinal spherulites of the 1:4 CIN in organogels in all oils. The CIN organogels in all oils (1:4) were observed to float in gastric media during the entire release study. The pharmacokinetic parameters of CIN in peppermint oil (1:4) revealed a close Cmax value to that of the 25 mg immediate-release tablet, but a different AUC. (4) Conclusions: The organogels in all oils floated throughout the release study, establishing their potential as a gastroretentive system. Furthermore, these dosage forms were assessed as a gastric-controlled system through in silico simulations, which enabled prediction of their pharmacokinetic parameters.

18 October 2024 in Maaen Journal for Medical Sciences
Verified
Journal Article
Open access
PDF file
HMHasanain Shakir Mahmood
Hasanain Shakir Mahmood
JAJinan M. Al-Mousawy
Jinan M. Al-Mousawy
JAJamal Ali Ashoor
Jamal Ali Ashoor
ASAshti M.H. Saeed
Ashti M.H. Saeed
AAAlaa Abdul Razzaq Al-Nuaimi
Alaa Abdul Razzaq Al-Nuaimi
PKPegah Khosravian
Pegah Khosravian
Sustainable technologies such as Additive manufacturing or three-dimensional printing (3D printing) have resulted in drastic changes in a number of industries including healthcare and pharmaceuticals. The current review focuses on the achievements accomplished on the effectiveness of three-dimensional printing in the field of drug designing and development. This technology is very precise and can be customized and that gives a way of developing complicated drug delivery systems and individualized medications. Promising areas of focus are the development of particular formulations of medicinal preparations, identification of new approaches to the drug release and potential creation of specific drug production for specific patients. However, some of the challenges that are identified include; regulatory challenges, barrier to materials and sources and considers directions for its integration into the normal practice of pharmaceutical industry. Remarkably, utilization of the opportunity provided by the 3D printing may result in changed positive effects on the increase of drug efficacy rates along with patient’s compliance with the prescribed medications and therefore, provide a positive shift in the treatment outcomes across the pharmaceutical segment as a whole.

30 September 2026 in Wiadomości Lekarskie
Verified
Journal Article
Closed access
PDF file
MAMaryam Alaayedi
Maryam Alaayedi
ZKZahraa Mohammed Kadhim
Zahraa Mohammed Kadhim
JAJamal Ali Ashoor
Jamal Ali Ashoor
ASAshti Mh Saeed
Ashti Mh Saeed
JAJinan M Al-Mousawy
Jinan M Al-Mousawy
MAMustafa H. Alhamadani
Mustafa H. Alhamadani
Aim: methotrexate was formulated as Ethosomal gel for enhancing the therapeutic performance and stability to treat cervical cancer via targeting the drug locally through cervical mucosa to avoid the systemic adverse effect of the chemotherapy. Materials and Methods: The formulations were produced using phospholipid and cholesterol then evaluated for particle size, polydispersity index, zeta potential, pH and drug release. The optimized ethosome formula then converted to gel. The gel evaluated for organoleptic properties, pH, viscosity and permeability. Results: The results showed than F8 was the best ethosomal formula with 34nm in size and 92% entrapment efficiency. This formula converted into gel had 1% gelling agent that was optimized ethosomal gel formula and gave better release that ordinary methotrexate gel with same type and percent of gelling agent. Conclusions: The drug was successfully formulated as ethosomal gel for treating cervical cancer topically in order to avoid the systemic exposure for the chemotherapy and its consequence adverse effect.